Abstract

Gynecologic cancers, including ovarian, cervical, endometrial, and vulvar cancers, present a significant global health burden for women. Effective risk assessment is crucial for early detection, prevention, and management of these cancers. This article explores the various risk factors associated with gynecologic malignancies, focusing on genetic predispositions, environmental exposures, and lifestyle factors. Additionally, it delves into the role of screening programs, biomarkers, and advanced imaging techniques in risk stratification. The article also emphasizes the importance of personalized approaches in managing high-risk individuals and the challenges faced in implementing widespread risk assessment strategies. Finally, it highlights ongoing research in the field of gynecologic oncology and its implications for improving patient outcomes.